Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2024

Accounting Policies [Abstract]

Summary of Impact of Accounts Receivable Reserves on Gross Trade Accounts Receivable Balances

The following table summarizes the impact of accounts receivable reserves on the gross trade accounts receivable balances as of September 30, 2024 and December 31, 2023:

In thousands	September 30, 2024			December 31, 2023
Gross trade accounts receivable	$	130,254		$	160,686
Trade allowances		(12,517	)		(18,834	)
Chargebacks		(5,095	)		(8,289	)
Accounts receivable, net	$	112,642		$	133,563

Calculation of Net Loss and Number of Shares Used to Compute Basic and Diluted Net Loss per Share

The calculation of net loss and the number of shares used to compute basic and diluted net loss per share for the three and nine months ended September 30, 2024 and 2023 are as follows:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
In thousands	2024			2023			2024			2023
Net loss—basic and diluted	$	(25,134	)	$	(19,311	)	$	(33,565	)	$	(53,331	)
Weighted average shares outstanding—basic and diluted		411,150			408,417			410,786			407,489
Loss per share—basic and diluted (1)	$	(0.06	)	$	(0.05	)	$	(0.08	)	$	(0.13	)

(1) Excluding the licensing revenue change in estimates and Medicaid change in estimate, both discussed in Note 7 – Revenue Recognition, net loss per share, basic and diluted, for the three months ended September 30, 2023 would have been $(0.06) and net loss per share for the nine months ended September 30, 2024 and 2023 would have been $(0.09) and $(0.19), respectively.

Anti-Dilutive Securities Not Included in the Computation of Net Loss per Share

For the three and nine months ended September 30, 2024 and 2023, the following potentially dilutive securities were not included in the computation of net loss per share because the effect would be anti-dilutive or because performance criteria were not yet met for awards contingent upon such measures:

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
In thousands	2024		2023		2024		2023
Stock options		29,071		27,797		29,071		27,797
Restricted stock and restricted stock units		14,696		13,676		14,696		13,676

Estimated Fair Value of Assets and Liability

The following tables present information about the estimated fair value of the Company’s assets and liabilities as of September 30, 2024 and December 31, 2023, and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value:

	September 30, 2024
In thousands	Total		Level 1		Level 2		Level 3
Asset:
Money Market Fund	$	73,927	$	73,927	$	—	$	—
U.S. Treasury Securities		165,720		165,720		—		—
Repo Securities		5,000		—		5,000		—
Total	$	244,647	$	239,647	$	5,000	$	—

	December 31, 2023
In thousands	Total		Level 1		Level 2		Level 3
Asset:
U.S. Treasury Securities	$	123,992	$	123,992	$	—	$	—
Money Market Fund		99,226		99,226		—		—
Agency Securities		8,912		—		8,912		—
Repo Securities		3,250		—		3,250		—
Total	$	235,380	$	223,218	$	12,162	$	—

Summary of Restructuring Charges

The following table sets forth the components of the Company's restructuring charges for the three and nine months ended September 30, 2023 (none in 2024):

	For the Three Months Ended September 30,		For the Nine Months Ended September 30,
In thousands	2023		2023
Restructuring expense	$	—	$	10,154
Vendor contract charges		711		589
Total restructuring expense		711		10,743
Restructuring inventory		12,674		39,228
Stock forfeitures		1,034		1,034
Total restructuring costs incurred	$	14,419	$	51,005

Change in Restructuring Liability

The following table shows the change in restructuring liability, which is included within accrued expenses and other current liabilities:

In thousands	Restructuring Liability
Balance at December 31, 2023	$	13,589
Costs incurred		—
Payments		(3,687	)
Balance at September 30, 2024	$	9,902